The Medical Advisor

What is DMSO? Dimethyl sulfoxide (DMSO) is a colorless, organic solvent derived from wood pulp during paper production. Discovered in the 19th century, it gained medical attention in the 1960s for its ability to rapidly penetrate skin and cell membranes, acting as an anti-inflammatory, analgesic, and tissue-protective agent.  While the FDA has approved it only for treating interstitial cystitis (a chronic bladder condition) via bladder instillation, anecdotal and clinical reports suggest broader uses for pain relief, wound healing, and more. It's often applied topically in diluted forms (e.g., 70% solution) but can cause side effects like garlic-like breath, skin irritation, or nausea at higher doses. Always consult a healthcare provider before use, as it's not regulated for most off-label applications. DMSO's history includes early promise for arthritis and injuries, halted by FDA concerns over eye toxicity in animal studies (later not replicated in humans). Despite this, ...

Introduction The potential applications of Ivermectin and Benzimidazole (Fenbendazole and Mebendazole) in cancer treatment have sparked significant interest online, with growing communities exploring these compounds for therapeutic use. While both have roots in anti-parasitic medicine, emerging research and anecdotal evidence suggest they may offer benefits in combating colorectal cancers. The main goal with this article is to provide as much clear information as possible for someone dealing with colorectal cancer. This article deals with the basis and practical approach to using Fenbendazole and Ivermectin for colorectal cancer. Can Fenbendazole and Ivermectin play a key role in treating Stage 4 Colorectal Cancer? Several peer-reviewed papers and case studies (below) strongly suggest that it might: Ivermectin, Fenbendazole and Mebendazole in Cancer: 2024 Peer-Reviewed Protocol in Cancer Ivermect...